Import Alert & DWPE Support
FDA Import Alert Testing Support and Sampling Coordination
When a product, manufacturer, or shipper appears on an FDA import alert, shipments can be detained automatically — without physical examination. We coordinate the shipment-by-shipment sampling, chain of custody, and independent laboratory testing that evidence-based responses are built on.
- DWPE Shipment Testing
- Accreditation-Aware Lab Matching
- Chain-of-Custody Documentation
- Multi-Shipment Record Keeping
Plain-Language Definition
What Is an FDA Import Alert?
An FDA import alert is a published instruction allowing FDA to detain future shipments of a product, or from a manufacturer or shipper, without physically examining each one — known as detention without physical examination, or DWPE. Once listed, every affected entry is presumed violative on arrival, and the burden shifts to the importer to demonstrate, shipment by shipment, that the goods comply.
Import alerts are organized by product category and violation type — common subjects include Salmonella and other pathogens in seafood and spices, pesticide residues in produce, filth, mycotoxins in nuts and grains, unapproved drug ingredients, and problem color additives in cosmetics. Each alert identifies the products, firms, or countries covered and the charge it carries.
See how the sampling process works for a detained entryKnow the Difference
How an Import Alert Differs From an Ordinary Detention
Both put your shipment on hold, but they are different problems requiring different responses.
- Triggered by FDA's review or examination of that specific entry
- Affects the single shipment named on the notice
- The response addresses that entry's stated violation
- A successful response resolves the matter for that shipment
- Future shipments are not automatically presumed violative
- Triggered by a published listing covering a product, firm, or shipper
- Every future affected shipment can be detained on arrival
- Each entry must be defended individually with evidence
- Releasing one shipment does not remove the listing
- Removal requires a petition supported by a documented compliance history
Import alert matters usually require a broader regulatory strategy than testing alone — typically involving a regulatory consultant or attorney. Sampling and laboratory evidence is a component of that strategy, not a substitute for it.
Where Testing Fits
The Two Places Laboratory Evidence Matters in an Import Alert Case
Testing serves two distinct goals for firms under an import alert — and the sampling discipline required is the same for both.
Track 1: Releasing the Current Shipment
Each detained entry can be defended individually. That typically means demonstrating, with evidence, that this specific shipment does not bear the violation the alert charges — and independent laboratory analysis of properly collected, custody-documented samples is often the core of that showing.
Coordinated per entry
- Representative sampling of the detained lot
- Chain-of-custody documentation
- Analysis matched to the alert's charge
- Reports organized for the responding parties
Track 2: Building a Removal Petition Record
Getting off the alert entirely requires petitioning FDA with evidence that the underlying problem is resolved. For many alerts, that record is commonly built on a documented history of consecutive non-violative shipments — often five, depending on the alert — each supported by consistent, credible testing and custody documentation.
Coordinated across shipments
- Consistent sampling and testing protocols per entry
- Accreditation-appropriate laboratories
- Organized multi-shipment records over time
- Documentation ready for the petitioning parties
Petition requirements vary by alert and are set by FDA. We do not prepare or file petitions — that is work for your regulatory consultant or attorney. We coordinate the sampling and testing evidence they build with.
Laboratory Accreditation
Why Laboratory Accreditation Matters for Import Alert Testing
Import alert testing is exactly where laboratory credentials get scrutinized. For certain food testing conducted to support admission of detained articles, FDA's Laboratory Accreditation for Analyses of Foods (LAAF) program may require the analysis to be performed by a LAAF-accredited laboratory — results from a non-qualifying lab may simply not count.
Whether LAAF or another accreditation applies depends on your product and the circumstances of the case, and it's confirmed during laboratory matching — before a single sample is pulled, not after results come back unusable.
Confirmed before testing begins
- Whether LAAF applies to your product and testing purpose
- The laboratory's accreditation scope covers your analysis
- The method fits the alert's specific charge
- Sample quantity and condition requirements
- Reporting format the responding parties need
Our Role
What We Coordinate for Import Alert Cases
The same disciplined logistics as any detention case — applied consistently, entry after entry, because import alert evidence is judged as a body of work.
Alert-Aware Case Intake
The alert number, its charge, and the FDA notice shape the whole plan — what must be tested, by what method, and to what documentation standard.
Per-Shipment Sampling
Representative collection at the holding facility, subject to authorization — planned around the lot structure and the laboratory's stated requirements.
How collection is documentedAccreditation-Aware Lab Matching
Independent laboratories matched to the alert's charge, the required method, and any accreditation the case demands — LAAF included where applicable.
Laboratory testing coordinationChain of Custody, Every Entry
Sealed, identified, transfer-documented samples on every shipment — because one weak custody record can taint an otherwise consistent history.
Sample Logistics
Packaging, temperature control, courier coordination, and laboratory receiving — the transport leg handled so samples arrive testable.
Multi-Shipment Record Organization
Reports, custody records, and photographs organized consistently across entries — so your consultant or attorney has a clean, cumulative record to work with.
Transparency
What Import Alert Testing Support Does Not Guarantee
Import alert cases attract exaggerated promises. Here is what no testing coordination — ours or anyone's — can guarantee.
This support does not guarantee:
- Release of any detained shipment
- Removal from an import alert
- A successful petition
- FDA acceptance of laboratory results
- A passing or specific test result
- That testing alone will resolve the listing
- Prevention of future detentions while listed
- Any specific regulatory outcome
Petition preparation, legal strategy, and regulatory representation are separate services provided by attorneys and regulatory consultants. FDA decides admissibility for each entry and decides petition outcomes on its own review.
Getting Started
How an Import Alert Testing Case Starts
-
Send the Notice and Alert Information
The FDA Notice of Action plus the import alert number and charge — these define the evidentiary standard from day one.
-
Confirm Product and Shipment Details
Product, lots, quantities, shipment location, and warehouse contact establish what collection is feasible.
-
Align With Your Regulatory Team
Your consultant or attorney sets the strategy — per-shipment release, petition record, or both — and we coordinate to it.
-
Execute and Document Consistently
Sampling, custody, testing, and record organization run to the same standard on every entry.
Common Questions
Import Alert Testing Questions
What does "detention without physical examination" (DWPE) mean?
DWPE means FDA can detain shipments covered by an import alert automatically, based on the published listing, without inspecting or sampling each one. The presumption flips: instead of FDA showing a problem with your entry, you must show your entry doesn't have the problem the alert charges.
That's why import alert entries so often turn on private laboratory evidence — it's frequently the importer's main tool for meeting that burden.
Will testing one shipment get my product off the import alert?
No. A successful response can win release of that individual shipment, but the listing remains, and the next shipment can be detained the same way. Removal from the alert requires a separate petition to FDA supported by a documented compliance history.
Anyone who tells you one clean test removes an alert is misinformed or misleading you.
How many clean shipments are needed to get off an alert?
It depends on the alert. For many, FDA commonly looks for evidence of multiple consecutive non-violative commercial shipments — often five — along with evidence that the underlying cause was corrected. The specific requirements are set out by FDA for each alert and situation.
Your regulatory consultant or attorney confirms what your petition needs; we coordinate the consistent sampling and testing evidence behind each of those shipments.
Do you prepare or file removal petitions?
No. Petition preparation and filing is regulatory strategy and advocacy work — the domain of attorneys and regulatory consultants. Presenting it otherwise would be doing you a disservice.
What we do is make the evidentiary backbone of a petition possible: consistent, documented, accreditation-appropriate sampling and testing on shipment after shipment, organized so your petitioning team can use it.
Does LAAF apply to my import alert testing?
Possibly. FDA's LAAF program can require certain food testing — including testing conducted to support admission of detained food — to be performed by a LAAF-accredited laboratory. Applicability depends on your product and the circumstances.
This is confirmed during laboratory matching, before collection, because results from a non-qualifying laboratory may not be usable for the purpose you paid for.
Can each shipment still be released while my firm is on the alert?
Yes — being listed doesn't make entries automatically refused, it makes them automatically detained. Each entry can be defended with evidence, and importers on alerts routinely obtain per-shipment releases while working toward removal.
It does mean planning testing into your import operations for every shipment, which is where consistent coordination pays off.
My manufacturer is listed, not my product. Am I still affected?
Likely yes, if your product comes from that manufacturer and falls within the alert's scope. Alerts can list products, manufacturers, shippers, growers, or geographic areas — the alert's own text defines who is covered.
Reading the specific alert against your supply chain is a job for your regulatory advisor; bring the alert number to intake and the coordination plan is built around its scope and charge.
How is import alert testing different from ordinary detention testing?
The laboratory work is similar; the standard and repetition differ. Import alert evidence gets judged against the alert's specific charge, may carry accreditation requirements like LAAF, and — if removal is the goal — must be consistent across multiple shipments over time rather than a one-off.
That's why the same protocols, documentation formats, and laboratory standards are applied entry after entry.
Looking for a Specific Import Alert?
We publish plain-language guides to the import alerts importers hit most — what each covers, the charge it carries, and the evidence it typically requires. Browse the import alert directory by number.
Start Your Case
Coordinate Testing for Your Import Alert Shipment
Send your FDA Notice of Action, the import alert number, product details, and shipment location. Your case will be reviewed and the sampling, laboratory, and documentation plan outlined — for this entry and, if needed, the ones after it.
Urgent detention matters receive priority intake review.
FDA Detention Sampling is an independent private company. We are not affiliated with, endorsed by, or part of the U.S. Food and Drug Administration. We do not prepare or file import alert petitions and do not provide legal or regulatory representation. Sampling, laboratory testing, documentation, and coordination services do not guarantee FDA release, admissibility, acceptance of laboratory results, removal from an import alert, or any specific regulatory outcome. FDA makes the final admissibility decision.